Cyto-reductive Surgery combined with Hyperthermic Intra-peritoneal Chemotherapy for Peritoneal Surface Malignancies:
Antonio Sommariva1, Pierluigi Pilati, Carlo Riccardo Rossi
1Melanoma and Sarcoma Unit, Veneto Institute of Oncology, National Cancer Institute - IRCCS, Padova, Italy. antonio.sommariva@ioveneto.it
Cancer Treatment Reviews
|August 3, 2011
Abstract:
Cyto-reductive Surgery (CS) combined with Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) as loco-regional treatment of Peritoneal Surface Malignancies (PSM) has increasingly gained acceptance in clinical practice. This review summarizes the more relevant studies on this topic. Indications, pre-operative work-up, technical aspects, outcome and future directions of this combined approach in the treatment of Peritoneal Surface Malignancies are discussed here and proposed in an informative and didactic manner.
